ClinicalTrials.gov
public full text
Public Domain
Efficacy Study of Δ9-THC to Treat Chronic Abdominal Pain
The main goal of this trial is to study the efficacy of Namisol® after a single dose of Δ9-THC in the treatment of pain resulting from chronic pancreatitis. Objective measures of pain processing, e.g. encephalography (EEG) and quantitative sensory testing (QST), are included to provide insight in underlying nociceptive processing.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis#1074666
- Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis#828391
- Nicotinamide Riboside for Diabetic Neuropathy#893680
- Chronic Pain Management During a Pandemic#1075498
- Development of a Noninvasive Metric to Measure Small Bowel Sensation - The Small Intestine Stress Test#862609
Record · ID 1030359
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive